Article

Pseudobulbar Affect: Considerations for Managed Care Professionals

https://www.pharmacytimes.org/landing/1073

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Marry Vuong, PharmD, BCPPS
Steven Daveluy, MD, dermatologist, Wayne State University
Michael Hassett, MD, MPH, Dana-Farber Cancer Institute
Related Content
Vaccine and syringe | Image credit: alernon77 - stock.adobe.com
August 17th 2025

Economic Benefits of Broad COVID-19 Vaccination in US Adults, by Age Group

Laura Joszt, MA
managed care cast banner
August 17th 2025

Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD

Mary Caffrey Skylar Jeremias Joseph Mikhael, MD
Modern Medical Technologies | Image credit: Prostock-studio - stock.adobe.com
August 17th 2025

Using AI, Socioeconomic Factors to Predict Outcomes After Allo-SCT for AML

Laura Joszt, MA
AJMC podcast banner
August 17th 2025

What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD

Hayden E. Klein Skylar Jeremias Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
FIT test | Image credit: TOimages - stock.adobe.com
August 17th 2025

Pharmacy-Based FIT Screening Could Boost Colorectal Cancer Detection

Pearl Steinzor
GLP-1's use, in theory should decrease preoperative risks more prevalent amongst those with obesity; however, safety considerations are still necessary. | Image Credit: AdobeStock_Anatta_Tan.jpeg
August 17th 2025

GLP-1s’ Preoperative Use Requires Safety Considerations

Sabrina McCrear

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo